Mechanisms and detection of carbapenem resistance in Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii

被引:6
作者
Urban, C
Rahal, JJ
机构
[1] New York Hosp Queens, Infect Dis Sect, Flushing, NY 11355 USA
[2] Cornell Univ, Dept Microbiol, New York, NY USA
[3] Cornell Univ, Dept Med, New York, NY USA
[4] Cornell Univ, Weill Med Coll, New York, NY USA
关键词
carbapenem resistance; Klebsiella pneumoniae; Acinetobacter baumannii; Pseudomonas aeruginosa; carbapenemase; efflux;
D O I
10.1097/01.revmedmi.0000131426.36224.82
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Numerous mechanisms of resistance to the carbapenems have been described in Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii. Resistance to this class of agents can be divided into three main categories that include beta-lactamases, efflux pumps, and changes in outer membrane porin proteins. Scant reports have also implicated penicillin-binding protein alterations in A. baumannii and P. aeruginosa. Inactivation of the carbapenems can be accomplished by a variety of beta-lactam hydrolysing enzymes. The IMP and VIM metallo-carbapenemases, belonging to the molecular class B family, are the most worrisome of all beta-lactamases because they confer resistance to the carbapenems and all other beta-lactam agents with the exception of aztreonam. Several molecular class A, C and D beta-lactamases have also demonstrated carbapenem hydrolysing activity but are less efficient in their capability. Efflux pumps, especially in P. aeruginosa, usually enhance resistance mediated by other mechanisms. Alterations in outer membrane porin proteins prevent or impede carbapenem penetration and subsequent binding to their targets in P. aeruginosa, K. pneumoniae, and A. baumannii. Finally, two or more of these mechanisms have been shown to act in concert to produce clinical resistance to carbapenems. Since expression of these mechanisms may be subtle, detection of carbapenem resistance in the clinical microbiology laboratory can be problematic. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 73 条
[1]   Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae [J].
Ahmad, M ;
Urban, C ;
Mariano, N ;
Bradford, PA ;
Calcagni, E ;
Projan, SJ ;
Bush, K ;
Rahal, JJ .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :352-355
[2]   Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems [J].
Ardanuy, C ;
Liñares, J ;
Domínguez, MA ;
Hernández-Allés, S ;
Benedi, VJ ;
Martínez-Martínez, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1636-1640
[3]   Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 β-lactamase production [J].
Armand-Lefèvre, L ;
Leflon-Guibout, V ;
Bredin, J ;
Barguellil, F ;
Amor, A ;
Pagès, JM ;
Nicolas-Chanoine, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) :1165-1168
[4]   NOVEL RESISTANCE TO IMIPENEM ASSOCIATED WITH AN ALTERED PBP-4 IN A PSEUDOMONAS-AERUGINOSA CLINICAL ISOLATE [J].
BELLIDO, F ;
VEUTHEY, C ;
BLASER, J ;
BAUERNFEIND, A ;
PECHERE, JC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (01) :57-68
[5]   Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme:: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases [J].
Bou, G ;
Cerveró, G ;
Domínguez, MA ;
Quereda, C ;
Martínez-Beltrán, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3299-3305
[6]   Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein [J].
Bradford, PA ;
Urban, C ;
Mariano, N ;
Projan, SJ ;
Rahal, JJ ;
Bush, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :563-569
[7]   Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2 [J].
Brown, S ;
Bantar, C ;
Young, HK ;
Amyes, SGB .
LANCET, 1998, 351 (9097) :186-187
[8]  
Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610
[9]   Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration [J].
Cao, VTB ;
Arlet, G ;
Ericsson, BM ;
Tammelin, A ;
Courvalin, P ;
Lambert, T .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :895-900
[10]   Metallo-β-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal [J].
Cardoso, O ;
Leitao, R ;
Figueiredo, A ;
Sousa, JC ;
Duarte, A ;
Peixe, LV .
MICROBIAL DRUG RESISTANCE, 2002, 8 (02) :93-97